TNF and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, an autocrine TNFα loop in human CML stem cells has already been shown to persist besides Bcr-Abl kinase inhibition in vitro [33] implying that this could present an attractive stem cell specific target.